Veterinary Diagnostics Market Set to Double by 2035 Amid Rising Pet Care Demand

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Global veterinary diagnostics market projected to double to $13.93 billion by 2035, driven by rising pet ownership and advanced medical care demand.

Veterinary Diagnostics Market Set to Double by 2035 Amid Rising Pet Care Demand

The global veterinary reference laboratory market is anticipated to expand substantially over the next decade, with valuations projected to reach USD 13.93 billion by 2035, compared to USD 6.12 billion in 2025, according to market analysis. This represents a compound annual growth rate of 8.58% throughout the forecast period, reflecting structural shifts in pet healthcare spending and diagnostic practices worldwide.

The expansion is primarily attributed to several converging factors, including the escalating global pet ownership rates and the increasing tendency among pet owners to seek advanced medical care for their animals. Additionally, the growing prevalence of zoonotic diseases and the rising adoption of sophisticated diagnostic technologies are compelling veterinary practitioners to utilize reference laboratory services at higher rates than historically observed.

Despite the positive growth trajectory, the market faces significant headwinds that could constrain expansion. Substantial capital requirements for establishing and maintaining laboratory infrastructure, combined with a critical shortage of qualified laboratory personnel in the veterinary sector, present notable challenges to market participants. These supply-side constraints may limit the pace at which new diagnostic capacity can be deployed to meet increasing demand.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 17

Related Coverage

Benzinga

Tech Stocks Hit Records as Oil Tumbles on Iran Strait Deal Hopes

Tech stocks hit records as Nasdaq 100 climbs to 28,706; crude oil falls 3% on Iran Strait deal hopes. Major earnings swings drive individual stocks.

NVDAMSFTTSLA
Benzinga

IDEXX Lifts 2026 Outlook as Pet Diagnostic Demand Accelerates

IDEXX Laboratories beats Q1 expectations and raises full-year guidance, citing stronger clinical visits and diagnostic frequency across its pet healthcare segment.

IDXX
Benzinga

Profusa Plunges 40% on $30M BioInsights Acquisition Despite Strategic Rationale

Profusa shares crashed 40% Tuesday after announcing $30M all-equity deal to acquire BioInsights' multi-omics diagnostics platform, expanding into molecular cancer detection.

PFSA
GlobeNewswire Inc.

Molecular Diagnostics Market to Nearly Triple to $43.5B by 2035 on Disease Detection Demand

Global molecular diagnostics market projected to grow from $18.26B in 2025 to $43.50B by 2035, driven by early disease detection demand and advanced technology adoption.

ILMNABTRHHBY
Benzinga

Co-Diagnostics Reports Sharp Revenue Decline, $46.9M Loss as Cash Reserves Dwindle

Co-Diagnostics ($CODX) posted $0.6M revenue and $46.9M net loss in 2025, down from prior year, amid strategic joint ventures and pipeline advancement.

CODX
The Motley Fool

Market Crash Fears Overblown: History Shows Resilience Through Volatility

Historical data suggests investors should stay confident despite current market turbulence. January gains predict positive annual returns 89% of the time.

AMZNMELIZTS